Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Asim Mohammed

Advanced Heart Failure and Transplant Cardiology Fort Wayne, IN Medical Doctor

NPI 1922285139 CMS profile 41778

7910 W Jefferson Blvd Ste 120, Fort Wayne, IN 46804

Open in the dashboard

General payments

$117,745

207 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$36,746 paid to institutions, not to them · program years 2021–2022

Through program year 2025, Asim Mohammed of Fort Wayne, IN is reported in the CMS Open Payments database as having received $117,745 across 207 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $36,746 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 88th percentile of Advanced Heart Failure and Transplant Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $386 15
2024 General $155 7
2023 General $22,968 29
2022 General $22,135 35
2021 General $11,978 47
2020 General $272 12
2019 General $59,851 62

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Asim Mohammed
  • Advanced Heart Failure and Transplant Cardiology median
  • Middle half of Advanced Heart Failure and Transplant Cardiology
  • National median

In program year 2025, general payments to Asim Mohammed were reported at $386. Among 967 Advanced Heart Failure and Transplant Cardiology profiles paid that year, the median was $1,024 and the middle half received between $289 and $6,890.

Show as a table
Year Asim Mohammed Advanced Heart Failure and Transplant Cardiology median Middle half National median
2019 $59,851 $863 $224–$4,562 $163
2020 $272 $452 $122–$3,992 $114
2021 $11,978 $550 $159–$3,571 $132
2022 $22,135 $729 $221–$4,357 $149
2023 $22,968 $1,002 $309–$5,827 $160
2024 $155 $931 $273–$5,204 $164
2025 $386 $1,024 $289–$6,890 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abiomed $51,263 34 payments
  2. Novartis Pharmaceuticals Corporation $47,443 48 payments
  3. Abbott Laboratories $7,838 72 payments
  4. AstraZeneca Pharmaceuticals LP $6,583 18 payments
  5. Merck Sharp & Dohme Corporation $3,568 6 payments
  6. Medtronic Vascular, Inc. $288 3 payments
  7. Impulse Dynamics (USA) Inc. $182 4 payments
  8. United Therapeutics Corporation $122 3 payments
  9. Lexicon Pharmaceuticals, Inc. $121 1 payment
  10. Regeneron Healthcare Solutions, Inc. $48 2 payments
  11. Other $290 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $44,425 18 payments
  2. Honoraria $39,600 8 payments
  3. Travel and Lodging $17,279 34 payments
  4. Consulting Fee $10,475 7 payments
  5. Food and Beverage $5,860 137 payments
  6. Education $107 3 payments
Products named General payments · program years 2019–2025
  1. Impella $51,263 34 payments
  2. ENTRESTO $40,715 40 payments
  3. FARXIGA $6,365 9 payments
  4. VERQUVO Cardiovascular $3,568 6 payments
  5. VERQUVO Cardiovascular $3,534 4 payments
  6. CARDIOMEMS $2,133 22 payments
  7. CardioMEMS HF System Cardiac Arrhythmias and Heart Failure $1,769 9 payments
  8. HeartMate 3 Left Ventricular Dev $1,391 4 payments
  9. HeartMate 3 Left Ventricular Assist Device $1,107 6 payments
  10. CardioMEMS HF System Heart failure $665 12 payments
  11. Other $2,270 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$14,584

Medicare's payments for the services billed

Medicare patients

65

Average age 70

Services billed

195

25 women, 40 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Diabetes 65%
Chronic kidney disease 58%
Atrial fibrillation 54%
COPD 42%
Arthritis 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • Regeneron Healthcare Solutions, Inc. $29
$29 — —
FUROSCIX
  • SCPHARMACEUTICALS INC. $26
$26 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

207 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Advanced Heart Failure and Transplant Cardiology in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record